Financials • Life Insurance
$41.37 ▲ +0.71
(+1.75%)
MKT CAP: $7.92B • VOL: 1.92M
52W L $32 52W H $48
LNC // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $18.21B | $18.44B | $11.64B |
| YoY Revenue Growth % | -1.2% | +58.4% | — |
| Gross Profit | $8.01B | $8.11B | $5.12B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.39B | $3.86B | -$887.4M |
| Operating Margin % | 7.6% | 21.0% | -7.6% |
| Net Income (GAAP) | $1.18B | $3.27B | -$752.0M |
| EBITDA (Normalized) | $2.04B | $4.53B | -$468.1M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$167.0M | -$2.01B | -$2.07B |
| Capital Expenditures (CapEx) | $819.5M | $829.9M | $524.0M |
| Free Cash Flow (FCF) | -$986.5M | -$2.84B | -$2.60B |
| FCF Margin % | -5.4% | -15.4% | -22.3% |
| Return on Invested Capital (ROIC %) | 0.7% | 2.2% | -8.3% |
| Cash & Short-Term Equivalents | $45.89B | $42.99B | $1.54B |
| Total Debt (Short + Long Term) | $182.83B | $172.15B | $3.27B |
| Total Stockholders' Equity | $10.91B | $8.27B | $6.71B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR LNC.